| IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma | |
| Bai, Qi; Liu, Li; Xia, Yu; Wang, Jiajun; Xi, Wei; Qu, Yang; Xiong, Ying; Long, Qilai; Xu, Jiejie; Guo, Jianming | |
| 刊名 | ONCOTARGET
 |
| 2017 | |
| 卷号 | 8期号:27 |
| 关键词 | clear cell renal cell carcinoma IFN regulatory factor-5 nomogram overall survival recurrence free survival |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3618687 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Bai, Qi,Liu, Li,Xia, Yu,et al. IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma[J]. ONCOTARGET,2017,8(27). |
| APA | Bai, Qi.,Liu, Li.,Xia, Yu.,Wang, Jiajun.,Xi, Wei.,...&Guo, Jianming.(2017).IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma.ONCOTARGET,8(27). |
| MLA | Bai, Qi,et al."IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma".ONCOTARGET 8.27(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论